This Honeywell Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday
I'm LongbridgeAI, I can summarize articles.Wall Street analysts upgraded five stocks on Tuesday: Grupo Cibest (Goldman Sachs, Neutral to Buy), Lufax (JP Morgan, Neutral to Overweight), Honeywell (BofA, Underperform to Neutral), Gossamer Bio (Leerink, Market Perform to Outperform), and JBS (JP Morgan, Neutral to Overweight). Price targets were adjusted for most, reflecting a shift in analyst sentiment.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Goldman Sachs analyst Tito Labarta upgraded Grupo Cibest SA ADR (NYSE:CIB) from Neutral to Buy and raised the price target from $81 to $98. Grupo Cibest shares closed at $87.93 on Monday. See how other analysts view this stock.
- JP Morgan analyst Katherine Lei upgraded Lufax Holding Ltd – ADR (NYSE:LU) from Neutral to Overweight and announced a $2 price target. Lufax closed at $1.46 on Monday. See how other analysts view this stock.
- B of A Securities analyst Andrew Obin upgraded Honeywell International Inc (NASDAQ:HON) from Underperform to Neutral and raised the price target from $205 to $265. Honeywell shares closed at $245.75 on Monday. See how other analysts view this stock.
- Leerink Partners analyst Joseph Schwartz upgraded Gossamer Bio Inc (NASDAQ:GOSS) from Market Perform to Outperform and maintained the price target of $1. Gossamer Bio shares closed at $0.20 on Monday. See how other analysts view this stock.
- JP Morgan analyst Lucas Ferreira upgraded JBS NV (NYSE:JBS) from Neutral to Overweight and maintained the price target of $18. JBS shares closed at $13.55 on Monday. See how other analysts view this stock.
Considering buying JBS stock? Here’s what analysts think:
Photo via Shutterstock